|
|
News Breaks | | | | October 19, 2012 | | 05:42 EDT |  | ABT | Abbott upgraded to Outperform from Market Perform at Wells Fargo Wells Fargo upgraded Abbott citing the recent pullback in shares. The firm has a $71-$74 price target range for shares. | |
|
News For ABT From The Last 14 Days Check below for free stories on ABT the last two weeks. |
|
|
| June 18, 2013 | | 07:28 EDT |  | ABT | Wells Faro to host a conference
Subscribe for More Information | | | June 14, 2013 | | 12:23 EDT |  | ABT | Abbott announces new $3B share repurchase plan
Subscribe for More Information | | | 12:23 EDT |  | ABT | Abbott announces new $3B share repurchase plan
| | | June 13, 2013 | | 11:02 EDT |  | ABT | Leerink's major pharma analyst holds an analyst/Industry conference call
Subscribe for More Information | | | June 11, 2013 | | 09:33 EDT |  | ABT | Abbott begins Absorb BVS clinical trial in Japan
Subscribe for More Information | | | June 6, 2013 | | 08:03 EDT |  | ABT | Abbott shares compelling, says Wells Fargo
Subscribe for More Information | | | June 4, 2013 | | 15:59 EDT |  | ABT | Abbott reports positive outcomes from European studies of MitraClip device Abbott announced publication of positive outcomes from two European post-approval studies of the first-in-class catheter-based MitraClip therapy for the treatment of mitral regurgitation. Results from ACCESS-EU, a European prospective study that enrolled 567 patients at 14 sites, have been published in the Journal of the American College of Cardiology. In addition, findings of the investigator-sponsored German TRAnscatheter Mitral Valve Interventions registry, which enrolled 1,064 patients at 20 German sites, were recently published in EuroIntervention. Abbott's MitraClip System, which received CE Mark in 2008 and is commercially available in Europe and other international markets, is an investigational device in the United States. The device is delivered to the heart through the femoral vein, a blood vessel in the leg, and is designed to reduce MR by clipping together a portion of the leaflets of the mitral valve to allow the heart to more efficiently pump blood. | |
|
|
|
|
|
|